Literature DB >> 3622557

Technetium-1,2-dihydroxy-1,2-bis(dihydroxyphosphinyl)ethane (99mTc-DHPE). A promising new skeletal imaging agent.

S C Archimandritis, A K Tsolis.   

Abstract

99mTc-sodium pertechnetate was reduced and complexed with 1,2-dihydroxy-1,2-bis(dihydroxyphosphinyl)ethane (DHPE) with a yield higher than 95%. When administered to rats, 99mTc-DHPE demonstrated very good skeletal uptake, a high clearance from blood to the bones a low concentration in muscles and other organs, satisfactory biological stability and a clearance mainly through the kidneys. The biodistribution of 99mTc-DHPE in rats compared to that of 99mTc-methylenediphosphonate (99mTc-MDP) at 2 and 24 h post injection, showed higher skeletal uptake, substantially higher blood clearance, but also higher concentration in muscles which, however, caused no significant degradation in image quality. These characteristics suggest that 99mTc-DHPE is a promising new skeletal imaging agent.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622557     DOI: 10.1007/bf00289025

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  12 in total

1.  A quick and reliable process for preparing 99mTc--1: hydroxy-ethylidene-1, 1-diphosphonic acid disodium salt (HEDSPA) using electrolysis.

Authors:  E P Belkas; A D Varvarigou
Journal:  Int J Appl Radiat Isot       Date:  1976-10

2.  A crossover study comparing Tc-99m-labeled HMDP and MDP in patients.

Authors:  L Rosenthall; A Arzoumanian; B U Damtew; J Tremblay
Journal:  Clin Nucl Med       Date:  1981-08       Impact factor: 7.794

3.  Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.

Authors:  G Subramanian; J G McAfee; R J Blair; F A Kallfelz; F D Thomas
Journal:  J Nucl Med       Date:  1975-08       Impact factor: 10.057

4.  Experimental examinations on the suitability of organoaminomethane-bis-phosphonic acids for bone-scintigraphy by means of Tc-99m in animals.

Authors:  S Unterspann
Journal:  Eur J Nucl Med       Date:  1976-08-12

5.  A study of the relationship between chemical structure and bone localization of Tc-99m diphosphonic acids: concise communication.

Authors:  T S Wang; G E Mojdehi; R A Fawwaz; P M Johnson
Journal:  J Nucl Med       Date:  1979-10       Impact factor: 10.057

6.  Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.

Authors:  J A Bevan; A J Tofe; J J Benedict; M D Francis; B L Barnett
Journal:  J Nucl Med       Date:  1980-10       Impact factor: 10.057

7.  Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.

Authors:  J A Bevan; A J Tofe; J J Benedict; M D Francis; B L Barnett
Journal:  J Nucl Med       Date:  1980-10       Impact factor: 10.057

8.  Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.

Authors:  T S Wang; R A Fawwaz; L J Johnson; G E Mojdehi; P M Johnson
Journal:  J Nucl Med       Date:  1980-08       Impact factor: 10.057

Review 9.  Skeletal uptake of diphosphonate: a review.

Authors:  I Fogelman
Journal:  Eur J Nucl Med       Date:  1980-12

10.  New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.

Authors:  G Subramanian; J G McAfee; F D Thomas; T A Feld; C Zapf-Longo; E Palladino
Journal:  Radiology       Date:  1983-12       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.